Add BrightSurf on Google Email

The American College of Medical Genetics and Genomics (ACMG) releases highly anticipated evidence-based clinical guideline for phenylalanine hydroxylase deficiency

The American College of Medical Genetics and Genomics has published a new evidence-based clinical guideline for phenylalanine hydroxylase deficiency diagnosis and management. The guideline provides recommendations for treatment, implementation considerations, research priorities, and economic considerations to improve patient outcomes.

SourceAmerican College of Medical Genetics and Genomics·JournalGenetics in Medicine·TypeSystematic review·DateDec 4, 2024